510 related articles for article (PubMed ID: 8505553)
1. Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues.
Temponi M; Kekish U; Hamby CV; Nielsen H; Marboe CC; Ferrone S
J Immunol Methods; 1993 May; 161(2):239-56. PubMed ID: 8505553
[TBL] [Abstract][Full Text] [Related]
2. mAb KUL/05 identifies a denaturation-resistant determinant shared by class II MHC products DR, DQ and DP.
Giacomini P; Tecce R; Nicotra MR; Cohen BB; Mazzilli MC; Natali PG
J Immunogenet; 1989 Jun; 16(3):203-16. PubMed ID: 2482314
[TBL] [Abstract][Full Text] [Related]
3. A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections.
Wang X; Campoli M; Cho HS; Ogino T; Bandoh N; Shen J; Hur SY; Kageshita T; Ferrone S
J Immunol Methods; 2005 Apr; 299(1-2):139-51. PubMed ID: 15896802
[TBL] [Abstract][Full Text] [Related]
4. HLA-D region alpha-chain monoclonal antibodies: cross-reaction between an anti-DP alpha-chain antibody and smooth muscle.
Thomas A; Lindsay J; Wilkinson M; Bodmer J
J Pathol; 1988 Apr; 154(4):353-63. PubMed ID: 2455029
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
6. Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens.
Horejsí V; Nĕmec M; Angelisová P; Kristofová H; Gorga JC; Hilgert I
Tissue Antigens; 1986 Nov; 28(5):288-97. PubMed ID: 2435017
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
[TBL] [Abstract][Full Text] [Related]
8. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma.
van Vreeswijk H; Ruiter DJ; Bröcker EB; Welvaart K; Ferrone S
J Invest Dermatol; 1988 May; 90(5):755-60. PubMed ID: 3283252
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a monoclonal antibody recognizing a monomorphic determinant of DR antigens.
Schütt C; Horejsi V; Walzel H; Siegl E
Biomed Biochim Acta; 1989; 48(4):359-63. PubMed ID: 2473743
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR, DP and DQ expression in the small intestine of patients with coeliac disease.
Marley NJ; Macartney JC; Ciclitira PJ
Clin Exp Immunol; 1987 Nov; 70(2):386-93. PubMed ID: 3322617
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.
Degener T; Momburg F; Möller P
Virchows Arch A Pathol Anat Histopathol; 1988; 412(4):315-22. PubMed ID: 3125670
[TBL] [Abstract][Full Text] [Related]
14. Activated T cells and monocytes have characteristic patterns of class II antigen expression.
Robbins PA; Maino VC; Warner NL; Brodsky FM
J Immunol; 1988 Aug; 141(4):1281-7. PubMed ID: 3135327
[TBL] [Abstract][Full Text] [Related]
15. Expression of HLA-DQ, -DR, and -DP antigens in normal kidney and glomerulonephritis.
Müller CA; Markovic-Lipkovski J; Risler T; Bohle A; Müller GA
Kidney Int; 1989 Jan; 35(1):116-24. PubMed ID: 2468811
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes.
Robbins PA; Evans EL; Ding AH; Warner NL; Brodsky FM
Hum Immunol; 1987 Apr; 18(4):301-13. PubMed ID: 3494718
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the expression of three different BoLA-class II molecules on the bovine BL-3 cell line: determination of a non-DR non-DQ gene product.
Ababou A; Goyeneche J; Davis WC; Lévy D
J Leukoc Biol; 1994 Aug; 56(2):182-6. PubMed ID: 7520928
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to sheep MHC class II molecules recognize all HLA-D or subsets of HLA-D region products.
Puri NK; de Kretser T; Brandon MR
Hum Immunol; 1987 Nov; 20(3):195-207. PubMed ID: 3501780
[TBL] [Abstract][Full Text] [Related]
19. Expression of HLA-A,B,C, beta 2-microglobulin (beta 2m), HLA-DR, -DP, -DQ and of HLA-D-associated invariant chain (Ii) in soft-tissue tumors.
Mechtersheimer G; Staudter M; Majdic O; Dörken B; Moldenhauer G; Möller P
Int J Cancer; 1990 Nov; 46(5):813-23. PubMed ID: 2228310
[TBL] [Abstract][Full Text] [Related]
20. Expression of major histocompatibility complex class II subregion products by jejunal epithelium in patients with coeliac disease.
Scott H; Sollid LM; Fausa O; Brandtzaeg P; Thorsby E
Scand J Immunol; 1987 Nov; 26(5):563-71. PubMed ID: 3500504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]